Neoplasms, Rectal
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human Papillomavirus [HPV] -16/18 Vaccine), When Administered According to the Approved Prescribing Information (PI) in Korea (NCT03671369) | GlaxoSmithKline | 2018-10-02 |
| Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer (NCT03573791) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2018-05-21 |
| Immunoscore in Rectal Cancer (NCT02017509) | Providence Health & Services | 2014-01-24 |
Track Neoplasms, Rectal automatically
Every clearance here is in the API, with alerts when new ones post.